Telix Pharmaceuticals Limited: Telix's ZIRCON Phase III Kidney Cancer Imaging Study Presented in Game Changing Session at EAU
MELBOURNE, Australia, March 13, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces additional positive results from its completed pivotal Phase